1. Home
  2. GRWG vs RNXT Comparison

GRWG vs RNXT Comparison

Compare GRWG & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GrowGeneration Corp.

GRWG

GrowGeneration Corp.

HOLD

Current Price

$1.42

Market Cap

89.6M

ML Signal

HOLD

Logo RenovoRx Inc.

RNXT

RenovoRx Inc.

HOLD

Current Price

$1.28

Market Cap

79.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRWG
RNXT
Founded
2008
2012
Country
United States
United States
Employees
N/A
N/A
Industry
RETAIL: Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
89.6M
79.4M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
GRWG
RNXT
Price
$1.42
$1.28
Analyst Decision
Buy
Strong Buy
Analyst Count
3
4
Target Price
$2.50
★ $7.13
AVG Volume (30 Days)
258.4K
★ 484.7K
Earning Date
11-05-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 51.22
20.00
EPS
★ N/A
N/A
Revenue
★ $193,365,479.00
$1,123,000.00
Revenue This Year
$2.59
$244.84
Revenue Next Year
$5.33
$195.26
P/E Ratio
★ N/A
N/A
Revenue Growth
142.51
★ 2511.63
52 Week Low
$1.01
$0.70
52 Week High
$2.40
$2.59

Technical Indicators

Market Signals
Indicator
GRWG
RNXT
Relative Strength Index (RSI) 37.34 40.59
Support Level $1.28 $0.83
Resistance Level $1.62 $1.30
Average True Range (ATR) 0.05 0.10
MACD -0.01 -0.01
Stochastic Oscillator 21.05 28.85

Price Performance

Historical Comparison
GRWG
RNXT

About GRWG GrowGeneration Corp.

GrowGeneration Corp owns and operates specialty retail stores focused on hydroponic and organic gardening. The company markets and distributes nutrients, growing media, indoor and greenhouse lighting, ventilation systems, and related accessories. It operates through two reportable segments: Cultivation and Gardening, which includes its hydroponic and organic gardening business, and Storage Solutions, which includes its benching, racking, and storage solutions operations. The company generates revenue mainly from the sale of proprietary and non-proprietary products through retail stores, e-commerce platforms, wholesale distribution, and commercial sales, along with the sale and installation of commercial fixtures.

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: